Related Experiment Video
Updated: Oct 30, 2025

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
Published on: July 12, 2021
Association between SCN1A polymorphism and carbamazepine responsiveness in epilepsy: A meta-analysis
Xuan Zhang1, Jia Liu1, Jing Ye1
1Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Background:
Carbamazepine (CBZ) is one of most used antiepileptic drugs. However, CBZ-resistance is common in patients with epilepsy, and genetic polymorphisms can influence antiepileptic drug responsiveness. The association between the polymorphisms rs3812718 and rs2298771 of theSCN1A gene and risk of resistance to CBZ in epilepsy remains controversial. To further assess the pooled association, we conducted an updated meta-analysis to investigate the contribution of the two SCN1A single nucleotide polymorphisms that may confer CBZ-resistance.
Methods:
We searched PubMed, Embase, and Web of Science databases for eligible studies. All the case-controlled studies related to the association of the SCN1A polymorphisms, rs3812718 and rs2298771, with CBZ-resistance in epilepsy were included. Pooled odds ratios (OR) as well as the corresponding 95 % confidence intervals (CI) were determined.
Results:
A total of eight out of 255 articles were used to assess the association between SCN1A and CBZ-resistance in epilepsy. We found a significant association between rs2298771 (GG vs GA + AA; OR 3.19, 95 % CI 1.27 - 8.02, p > 0.05, I2 = 0) and CBZ-resistance in epilepsy patients of Asian ethnicity. No association was observed between the rs3812718 polymorphism and CBZ responsiveness.
Conclusion:
Our results indicate that Asian patients with epilepsy and the SCN1A rs2298771 polymorphism, especially the GG genotype, may be at risk of CBZ-resistance.
More Related Videos
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
07:01Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Related Concept Videos
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types: